DOXORUBICIN and PYREXIA

Overview

PYREXIA is the #6 most commonly reported adverse reaction for DOXORUBICIN, manufactured by Amneal Pharmaceuticals LLC. There are 3,894 FDA adverse event reports linking DOXORUBICIN to PYREXIA. This represents approximately 2.6% of all 148,755 adverse event reports for this drug.

Patients taking DOXORUBICIN who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for DOXORUBICIN, but still significant enough to appear in the safety profile.

Other Side Effects of DOXORUBICIN

In addition to pyrexia, the following adverse reactions have been reported for DOXORUBICIN:

• FEBRILE NEUTROPENIA — 8,717 reports
• OFF LABEL USE — 8,461 reports
• DISEASE PROGRESSION — 6,242 reports
• NEUTROPENIA — 6,180 reports
• DRUG INEFFECTIVE — 4,974 reports
• THROMBOCYTOPENIA — 3,634 reports
• ANAEMIA — 3,623 reports
• DEATH — 3,039 reports
• NAUSEA — 3,033 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 2,932 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does DOXORUBICIN cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,894 FDA reports for DOXORUBICIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with DOXORUBICIN?

PYREXIA accounts for approximately 2.6% of all adverse event reports for DOXORUBICIN, making it a notable side effect.

What should I do if I experience PYREXIA while taking DOXORUBICIN?

If you experience pyrexia while taking DOXORUBICIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages